World Health Summit delegates approve $13.2M prevention-and-early-protection package
- Amref Health Africa and the Novo Nordisk Foundation used the World Health Summit meeting in Nairobi on April 28 to launch a $13.2 million East Africa program. - The money funds a three-year expansion of PEP across Kenya, Uganda, Tanzania, and Ethiopia, with 55 training institutions targeted for cardiometabolic care upgrades. - This matters because the package is really a workforce bet — shifting from short-term disease campaigns toward Africa-led training systems.
The news here is not a new drug or a new hospital wing. It is a training push — and that matters more than it sounds at first glance. On April 28, at the World Health Summit Regional Meeting in Nairobi, Amref Health Africa and the Novo Nordisk Foundation announced a $13.2 million package to expand the Partnership for Education of Health Professionals, or PEP, across East Africa. The target is cardiometabolic disease — basically the big cluster that includes heart disease and diabetes — and the bet is that the real bottleneck is not only medicine, but the people trained to prevent, spot, and manage these illnesses. (newsroom.amref.org) ### What actually got approved? Amref is getting a $13.2 million grant as one main component of a broader new PEP phase. That Amref-led piece runs for three years and expands work across Kenya, Uganda, Tanzania, and Ethiopia. The program is being rolled out on the sidelines of the World Health Summit’s April 27–29 Nairobi meeting, which this year is centered on rebuilding African health systems around innovation, integration, and interdependence. (novonordiskfonden.dk) ### What is PEP? PEP stands for Partnership for Education of Health Professionals. It is a Novo Nordisk Foundation flagship program that started in 2022 and is built around a simple idea — if clinics are overwhelmed by chronic disease, you cannot fix that only by sh(novonordiskfonden.dk) East Africa, with a focus on equitable prevention and care for cardiometabolic disease. (novonordiskfonden.dk) ### Why focus on training instead of treatment? Because East Africa’s disease burden has shifted faster than its training systems. Infectious diseases still matter, but heart disease and diabetes are rising at the same time. Many training institutions are still working with outdated curricula, weak digital infrastructure, and too little practical training. That lea(novonordiskfonden.dk)actly what chronic disease demands. (newsroom.amref.org) ### What will the money pay for? The program aims to support 55 training institutions. The work includes updated competency-based teaching, stronger faculty support, clinical mentorship, and more digital, blended, and simulation-based learning. In plain English, this is less about building a flashy new center and more about rewiring how existing institutions teach people before they reach the clinic floor. (newsroom.amref.org) ### Why cardiometabolic disease? Because it is already a huge share of the problem. Amref says cardiometabolic diseases and other non-communicable diseases account for about 40% of all deaths in East Africa. That is the quiet shift underneath this whole announcement — health systems built around acute infectious threats now also have to handle lifelong conditions that need routine screening, counseling, referral, and follow-up. (newsroom.amref.org) ### Why does the Nairobi summit matter here? The summit gave this announcement a political frame, not just a funding frame. The meeting in Nairobi is explicitly about Africa shaping its own health agenda, and its hosts have leaned hard into the idea that African in(newsroom.amref.org)of one-off campaigns. (worldhealthsummit.org) ### Is this the whole story? Not quite. The $13.2 million figure is the Amref-led part, not the entire new PEP phase. Novo Nordisk Foundation says the broader East Africa phase totals DKK 145 million, or about $22.7 million. So if you saw posts treating $13.2 million as the whole initiative, that misses the bigger structure. (novonordiskfonden.dk)are-in-relation-to-cardiometabolic-diseases-in-east-africa/)) ### Bottom line? This package is a systems play. The immediate headline is $13.2 million, but the deeper story is that donors and African health institutions are trying to move upstream — from treating late-stage disease to building the workforce that can catch it earlier and manage it better. If that works, the payoff is not one splashy breakthrough. It is fewer missed diagnoses, better routine care, and health systems that are less brittle a few years from now. (newsroom.amref.org)
